Haemonetics vs LifeStance Health Group
Haemonetics (HAE), health care, and LifeStance Health Group (LFST), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Haemonetics is worth $5.5B on the stock market and LifeStance Health Group $5.4B: Haemonetics is valued at 2% more. Haemonetics trades at 53.5 times earnings and LifeStance Health Group at 78.7; operating margins in their latest fiscal years were 11.7% and 1.70%. Over the past year Haemonetics's share price has moved +63.1% and LifeStance Health Group's +134%.
Key facts
- Haemonetics market value
- $5.5B
- LifeStance Health Group market value
- $5.4B
- Haemonetics P/E
- 53.5
- LifeStance Health Group P/E
- 78.7
- Haemonetics revenue
- $1.3BFY to 2026-03-28
- LifeStance Health Group revenue
- $1.4BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Haemonetics | LifeStance Health Group |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-03-28 | 2025-12-31 |
| Size | ||
| Market cap | $5.5Bhigher | $5.4Blower |
| Revenue | $1.3Blower | $1.4Bhigher |
| Earnings | $97.3Mhigher | $9.7Mlower |
| Employees | 3,009lower | 8,863higher |
| Total assets | $2.4Bhigher | $2.2Blower |
| Valuation | ||
| P/E | 53.5lower | 78.7higher |
| P/S | 4.1higher | 3.8lower |
| P/B | 6.1higher | 3.6lower |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | 11.7%higher | 1.70%lower |
| Balance sheet | ||
| Net assets | $796.3Mlower | $1.5Bhigher |
| Total liabilities | $1.6Bhigher | $682.9Mlower |
| Total debt | $1.2Bhigher | $282.8Mlower |
| Cash on hand | $245.4Mlower | $248.6Mhigher |
| Price change | ||
| Today | -0.35%higher | -2.14%lower |
| 1 year | +63.1%lower | +134%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Haemonetics only (1)
- John Rogers2.4%
LifeStance Health Group only (1)
- Matthew McLennan<0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns HAE · Who owns LFST
More on Haemonetics
Further comparisons
Haemonetics against its closest peers
LifeStance Health Group against its closest peers
Learn
Questions and answers
Which is bigger, Haemonetics or LifeStance Health Group?
By market value, Haemonetics is the larger: $5.5B against $5.4B for LifeStance Health Group. By revenue in its latest fiscal year, LifeStance Health Group is the larger: $1.4B against $1.3B for Haemonetics.
Which has the higher P/E ratio?
LifeStance Health Group: 78.7, against 53.5 for Haemonetics. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Haemonetics: 11.7%, against 1.70% for LifeStance Health Group. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Haemonetics: $1.2B, against $282.8M for LifeStance Health Group. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Haemonetics and LifeStance Health Group?
None of the tracked superinvestors holds both in their latest 13F filing. 1 holds Haemonetics and 1 holds LifeStance Health Group.
Cite this page
Funkfolio, “Haemonetics vs LifeStance Health Group”, data as of 18 November 2026. https://funkfolio.com/compare/hae-vs-lfst
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.